CD4+/CD8+ T Lymphocytes Imbalance in Children with Severe 2009 Pandemic Influenza A (H1N1) Pneumonia

Overview

Journal Korean J Pediatr

Specialty Pediatrics

Date 2011 Aug 11

PMID 21829412

Citations 10

Authors

Ji Eun Kim

Siegfried Bauer

Kyong Suk La

Kee Hyoung Lee

Ji Tae Choung

Kyoung Ho Roh

Chang Kyu Lee

Young Yoo

Affiliations

Soon will be listed here.

Abstract

Purpose: This study was conducted to investigate the immune responses of children with moderate and severe novel influenza A virus (H1N1) pneumonia, and to compare their clinical and immunological findings with those of control subjects.

Methods: Thirty-two admitted patients with H1N1 pneumonia were enrolled in the study. The clinical profiles, humoral and cell-mediated immune responses of the 16 H1N1 pneumonia patients who were admitted to the pediatric intensive care unit (severe pneumonia group), 16 H1N1 pneumonia patients admitted to the pediatric general ward (moderate pneumonia group) and 13 control subjects (control group) were measured.

Results: Total lymphocyte counts were significantly lower in patients with H1N1 pneumonia than in the control group (P=0.02). The number of CD4+ T lymphocytes was significantly lower in the severe pneumonia group (411.5±253.5/µL) than in the moderate pneumonia (644.9±291.1/µL, P=0.04) and control (902.5±461.2/µL, P=0.01) groups. However, the number of CD8+ T lymphocytes was significantly higher in the severe pneumonia group (684.2±420.8/µL) than in the moderate pneumonia (319.7±176.6/µL, P=0.02) and control (407.2±309.3/µL, P=0.03) groups. The CD4+/CD8+ T lymphocytes ratio was significantly lower in the severe pneumonia group (0.86±0.24) than in the moderate pneumonia (1.57±0.41, P=0.01) and control (1.61±0.49, P=0.01) groups. The serum levels of IgG, IgM and IgE were significantly higher in the severe pneumonia group than in the 2 other groups.

Conclusion: The results of this study suggest that increased humoral immune responses and the differences in the CD4+ and CD8+ T lymphocyte profiles, and imbalance of their ratios may be related to the severity of H1N1 pneumonia in children.

Citing Articles

Predictive Value of IL-6 and Lymphocyte Subsets for Death in Children With Influenza-Associated Encephalopathy A Retrospective Study.

Sun R, Zhang X, Hou J, Jia W, Li P, Wang D Mediators Inflamm. 2024; 2024:5564727.

PMID: 39624480 PMC: 11611401. DOI: 10.1155/mi/5564727.

Analysis of clinical characteristics and risk factors for death due to severe influenza in children.

Sun R, Zhang X, Jia W, Li P, Song C Eur J Clin Microbiol Infect Dis. 2024; 43(3):567-575.

PMID: 38240989 DOI: 10.1007/s10096-024-04759-1.

Review of the potential pharmacological role of erucic acid: a monounsaturated omega-9 fatty acid.

Kazmi I, Afzal M, Al-Abbasi F, Alghamdi S, Alghamdi A, Alzarea S Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(6):3663-3674.

PMID: 38060041 DOI: 10.1007/s00210-023-02875-x.

A Comparative Study of Severe and Critical Influenza B in Children in the 2021-2022 Winter Season.

Li P, Liu X, Lang Y, Cui X, Shi Y Int J Gen Med. 2022; 15:7995-8001.

PMID: 36337673 PMC: 9635463. DOI: 10.2147/IJGM.S385307.

An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice.

Zhao Y, Zhao L, Li Y, Liu Q, Deng L, Lu Y Vet Microbiol. 2022; 271:109491.

PMID: 35714529 PMC: 9181763. DOI: 10.1016/j.vetmic.2022.109491.

References

Robinson M, ODonohoe J, Dadian G, Wankowicz A, Barltrop D, Hobbs J . An analysis of the normal ranges of lymphocyte subpopulations in children aged 5-13 years. Eur J Pediatr. 1996; 155(7):535-9. DOI: 10.1007/BF01957900. View

Moskophidis D, Kioussis D . Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med. 1998; 188(2):223-32. PMC: 2212460. DOI: 10.1084/jem.188.2.223. View

Dawood F, Jain S, Finelli L, Shaw M, Lindstrom S, Garten R . Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 360(25):2605-15. DOI: 10.1056/NEJMoa0903810. View

Doherty P . Cytotoxic T cell effector and memory function in viral immunity. Curr Top Microbiol Immunol. 1996; 206:1-14. DOI: 10.1007/978-3-642-85208-4_1. View

Giamarellos-Bourboulis E, Raftogiannis M, Antonopoulou A, Baziaka F, Koutoukas P, Savva A . Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One. 2009; 4(12):e8393. PMC: 2792719. DOI: 10.1371/journal.pone.0008393. View

Cui W, Zhao H, Lu X, Wen Y, Zhou Y, Deng B . Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis. 2010; 10:145. PMC: 2890005. DOI: 10.1186/1471-2334-10-145. View

Libster R, Bugna J, Coviello S, Hijano D, Dunaiewsky M, Reynoso N . Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med. 2009; 362(1):45-55. DOI: 10.1056/NEJMoa0907673. View

Bruder D, Srikiatkhachorn A, Enelow R . Cellular immunity and lung injury in respiratory virus infection. Viral Immunol. 2006; 19(2):147-55. DOI: 10.1089/vim.2006.19.147. View

Nichols J, Niles J, Roberts Jr N . Human lymphocyte apoptosis after exposure to influenza A virus. J Virol. 2001; 75(13):5921-9. PMC: 114307. DOI: 10.1128/JVI.73.13.5921-5929.2001. View

10.

Tu W, Mao H, Zheng J, Liu Y, Chiu S, Qin G . Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol. 2010; 84(13):6527-35. PMC: 2903266. DOI: 10.1128/JVI.00519-10. View

11.

Miroballi Y, Scott Baird J, Zackai S, Cannon J, Messina M, Ravindranath T . Novel influenza A(H1N1) in a pediatric health care facility in New York City during the first wave of the 2009 pandemic. Arch Pediatr Adolesc Med. 2010; 164(1):24-30. DOI: 10.1001/archpediatrics.2009.259. View

12.

Perez-Padilla R, Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E . Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009; 361(7):680-9. DOI: 10.1056/NEJMoa0904252. View

13.

Mauad T, Hajjar L, Callegari G, da Silva L, Schout D, Galas F . Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2009; 181(1):72-9. DOI: 10.1164/rccm.200909-1420OC. View

14.

Tran T, Nguyen T, Nguyen T, Luong T, Pham P, Nguyen V . Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 2004; 350(12):1179-88. DOI: 10.1056/NEJMoa040419. View

15.

Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R . Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis. 2005; 11(2):201-9. PMC: 3320461. DOI: 10.3201/eid1102.041061. View

16.

Louie J, Acosta M, Winter K, Jean C, Gavali S, Schechter R . Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009; 302(17):1896-902. DOI: 10.1001/jama.2009.1583. View

17.

Subbarao K, Murphy B, Fauci A . Development of effective vaccines against pandemic influenza. Immunity. 2006; 24(1):5-9. DOI: 10.1016/j.immuni.2005.12.005. View

18.

Jadavji T, Law B, Lebel M, Kennedy W, Gold R, Wang E . A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ. 1997; 156(5):S703-11. PMC: 1232848. View